RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Results of the GO-AFTER Study
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 5
SP 15
OP 16
DO 10.1177/155989770800800509
UL http://mdc.sagepub.com/content/8/5/15.abstract
AB This article reviews data from the GO-AFTER Study [NCT00264550], the first prospective, randomized, double-blind, placebo-controlled study that evaluated the efficacy and safety of a TNF inhibitor (golimumab) in patients with active rheumatoid arthritis who were previously exposed to another TNF inhibitor.